Webcast : Integrating Quadruplet Regimens in Newly Diagnosed Multiple Myeloma (NDMM) : Patient Focused Strategies to Improve Outcomes

Integrating Quadruplet Regimens in Newly Diagnosed Multiple Myeloma (NDMM) : Patient Focused Strategies to Improve Outcomes is organized by Practice Point Communications (PPC).

Launch Date: July 17, 2024
Release Date: June 26, 2024
Expiration Date: June 30, 2025

Description:
In these mini-modules, expert faculty inform and guide participants on latest developments from clinical trials on quadruplet and triplet regimens, based on updates from the European Hematology Association (EHA) 2024 meeting. By using clinical case scenarios, this activity clarifies clinical endpoints and outcomes to enable safe and effective frontline regimen choices among diverse patients with newly diagnosed multiple myeloma (NDMM) who have distinct needs. Dr. Orlowski, Dr. Raje, and Dr. Voorhees lay the foundation for optimal first-line, maintenance, transplantation, and subsequent therapy choice based on the risk profile of patients, to ultimately improve outcomes in multiple myeloma (MM).